Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travatan in Open-angle Glaucoma or Ocular Hypertension
NCT00051168Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2006
- Primary completion
- Mar 2009
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of travoprost in Open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Intraocular Pressure at 5 years. Started Jan 2006; status: completed.
02
Drugs
travoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00051168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00051168.